Home

Thirty-plus years of medical research have put Dr. Dale Bredesen, the Chief Science Officer (CSO) of Apollo Health, at the forefront of research into Alzheimer’s disease prevention and memory-loss reversal. His research teams have made discoveries that changed our understanding of the fundamental nature of Alzheimer’s disease and led to revolutionary treatments.

At Apollo Health, we turned Dr. Bredesen’s protocol into action and put the health of your brain back in your hands with the only Bredesen-approved Protocol for preventing, treating, and reversing Alzheimer’s disease and cognitive decline.

Dr. Dale Bredesen, CSO for Apollo Health, was the first neurodegenerative disease researcher to publish peer-reviewed groundbreaking studies on reversing cognitive decline in Alzheimer’s disease. Everyone knows a cancer survivor, but no one knows an Alzheimer’s survivor, until now.

The following studies shattered preconceived notions and beliefs that Alzheimer’s is unsurvivable, fostering hope for those facing cognitive decline or caring for someone who is.

• Reversal of cognitive decline: a novel therapeutic program (Aging, 2014)
• Reversal of cognitive decline in Alzheimer’s disease (Aging, 2016)
• Reversal of Cognitive Decline: 100 Patients – (Journal of Alzheimer’s Disease & Parkinsonism, 2018)

Apollo Health is building the first-ever community around the prevention and reversal of cognitive decline. Our vision is to build communities that support our participants throughout their journeys to manage brain health. Our community members have access to the resources and guides they need to be successful. Apollo Health’s Community encompasses a professional care team of support staff that works with our participants on the One-time ReCODE Report, the ReVERSE Program, and the Bredesen Protocol.

An internationally-recognized expert in the mechanisms of neurodegenerative diseases, Dr. Dale Bredesen’s career has been guided by a simple idea: that Alzheimer’s as we know it is not just preventable, but reversible. Thanks to a dedicated pursuit of finding the science that makes this a reality, his idea has placed Dr. Bredesen at the vanguard of neurological research and led to the discoveries that today underlie the ReCode Report.

Dr. Bredesen is a prodigious innovator in medicine, with over thirty patents to his name. Notably, he put much of his findings and research into the 2017 New York Times bestseller The End of Alzheimer’s.